Cargando…

Surgical Management of Appendicular Skeletal Metastases in Thyroid Carcinoma

Background. Bone is a frequent site of metastasis from thyroid carcinoma, but prognostic factors for patients who have surgery for thyroid carcinoma bone metastases are poorly understood. Methods. A retrospective review at a single institution identified 41 patients that underwent surgery in the app...

Descripción completa

Detalles Bibliográficos
Autores principales: Satcher, Robert L., Lin, Patrick, Harun, Nursat, Feng, Lei, Moon, Bryan S., Lewis, Valerae O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530792/
https://www.ncbi.nlm.nih.gov/pubmed/23304478
http://dx.doi.org/10.1155/2012/417086
_version_ 1782254065987616768
author Satcher, Robert L.
Lin, Patrick
Harun, Nursat
Feng, Lei
Moon, Bryan S.
Lewis, Valerae O.
author_facet Satcher, Robert L.
Lin, Patrick
Harun, Nursat
Feng, Lei
Moon, Bryan S.
Lewis, Valerae O.
author_sort Satcher, Robert L.
collection PubMed
description Background. Bone is a frequent site of metastasis from thyroid carcinoma, but prognostic factors for patients who have surgery for thyroid carcinoma bone metastases are poorly understood. Methods. A retrospective review at a single institution identified 41 patients that underwent surgery in the appendicular skeleton for thyroid carcinoma bone metastasis from 1988 to 2011. Results. Overall patient survival probability by Kaplan-Meier analysis after surgery for bone metastasis was 72% at 1 year, 29% at 5 years, and 20% at 8 years. Patients who had their tumor excised (P = 0.001) or presented with solitary bone involvement had a lower risk of death following surgery adjusting for age and gender. Disease progression at the surgery site occurred more frequently with a histological diagnosis of follicular carcinoma compared with other subtypes (P = 0.023). Multivariate analysis showed that tumor subtype, chemotherapy, and preoperative radiation treatment had no effect on survival after surgery. Patients treated with radioactive iodine had better survival following thyroidectomy, but not following surgery for bone metastases. Conclusions. For patients undergoing surgery for thyroid cancer bone metastasis, resection of the bone metastasis, if possible, has a survival benefit.
format Online
Article
Text
id pubmed-3530792
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-35307922013-01-09 Surgical Management of Appendicular Skeletal Metastases in Thyroid Carcinoma Satcher, Robert L. Lin, Patrick Harun, Nursat Feng, Lei Moon, Bryan S. Lewis, Valerae O. Int J Surg Oncol Clinical Study Background. Bone is a frequent site of metastasis from thyroid carcinoma, but prognostic factors for patients who have surgery for thyroid carcinoma bone metastases are poorly understood. Methods. A retrospective review at a single institution identified 41 patients that underwent surgery in the appendicular skeleton for thyroid carcinoma bone metastasis from 1988 to 2011. Results. Overall patient survival probability by Kaplan-Meier analysis after surgery for bone metastasis was 72% at 1 year, 29% at 5 years, and 20% at 8 years. Patients who had their tumor excised (P = 0.001) or presented with solitary bone involvement had a lower risk of death following surgery adjusting for age and gender. Disease progression at the surgery site occurred more frequently with a histological diagnosis of follicular carcinoma compared with other subtypes (P = 0.023). Multivariate analysis showed that tumor subtype, chemotherapy, and preoperative radiation treatment had no effect on survival after surgery. Patients treated with radioactive iodine had better survival following thyroidectomy, but not following surgery for bone metastases. Conclusions. For patients undergoing surgery for thyroid cancer bone metastasis, resection of the bone metastasis, if possible, has a survival benefit. Hindawi Publishing Corporation 2012 2012-12-12 /pmc/articles/PMC3530792/ /pubmed/23304478 http://dx.doi.org/10.1155/2012/417086 Text en Copyright © 2012 Robert L. Satcher et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Satcher, Robert L.
Lin, Patrick
Harun, Nursat
Feng, Lei
Moon, Bryan S.
Lewis, Valerae O.
Surgical Management of Appendicular Skeletal Metastases in Thyroid Carcinoma
title Surgical Management of Appendicular Skeletal Metastases in Thyroid Carcinoma
title_full Surgical Management of Appendicular Skeletal Metastases in Thyroid Carcinoma
title_fullStr Surgical Management of Appendicular Skeletal Metastases in Thyroid Carcinoma
title_full_unstemmed Surgical Management of Appendicular Skeletal Metastases in Thyroid Carcinoma
title_short Surgical Management of Appendicular Skeletal Metastases in Thyroid Carcinoma
title_sort surgical management of appendicular skeletal metastases in thyroid carcinoma
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530792/
https://www.ncbi.nlm.nih.gov/pubmed/23304478
http://dx.doi.org/10.1155/2012/417086
work_keys_str_mv AT satcherrobertl surgicalmanagementofappendicularskeletalmetastasesinthyroidcarcinoma
AT linpatrick surgicalmanagementofappendicularskeletalmetastasesinthyroidcarcinoma
AT harunnursat surgicalmanagementofappendicularskeletalmetastasesinthyroidcarcinoma
AT fenglei surgicalmanagementofappendicularskeletalmetastasesinthyroidcarcinoma
AT moonbryans surgicalmanagementofappendicularskeletalmetastasesinthyroidcarcinoma
AT lewisvaleraeo surgicalmanagementofappendicularskeletalmetastasesinthyroidcarcinoma